Literature DB >> 22148038

Syringocystadenoma papilliferum of the back combined with a tubular apocrine adenoma.

Hyun Joo Lee1, Eujin Cho, Min Ho Kim, Sang Hyun Cho, Jeong Deuk Lee.   

Abstract

Syringocystadenoma papilliferum (SCAP) and tubular apocrine adenoma (TAA) are rare benign sweat gland tumors. SCAP and TAA may have a histopathologic overlap, but few cases of a SCAP combined with a TAA have been reported. Herein we describe an unusual case of a SCAP co-existing with a TAA located on the back of a 12-year-old girl.

Entities:  

Keywords:  Back; Syringocystadenoma papilliferum; Tubular apocrine adenoma

Year:  2011        PMID： 22148038      PMCID： PMC3229053          DOI： 10.5021/ad.2011.23.S2.S151

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN： 1013-9087            Impact factor:   1.444


  14 in total

1.  A case of tubular apocrine adenoma with syringocystadenoma papilliferum arising in nevus sebaceus.

Authors:  Bong Kyun Ahn; Yoon-Kee Park; You Chan Kim
Journal:  J Dermatol       Date:  2004-06       Impact factor: 4.005

2.  Naevus sebaceus on the female breast accompanied with a tubular apocrine adenoma and a syringocystadenoma papilliferum.

Authors:  N Yamane; N Kato; T Yanagi; R Osawa
Journal:  Br J Dermatol       Date:  2007-06       Impact factor: 9.302

3.  A case of tubular apocrine adenoma with syringocystadenoma papilliferum.

Authors:  S Ansai; S Watanabe; K Aso
Journal:  J Cutan Pathol       Date:  1989-08       Impact factor: 1.587

4.  Tubular apocrine adenoma.

Authors:  J Toribio; A Zulaica; C Peteiro
Journal:  J Cutan Pathol       Date:  1987-04       Impact factor: 1.587

5.  An unusual presentation of a congenital benign apocrine hamartoma.

Authors:  B A Epstein; Z B Argenyi; G Goldstein; D Whitaker
Journal:  J Cutan Pathol       Date:  1990-02       Impact factor: 1.587

6.  A Case of Tubular Apocrine Adenoma with Syringocystadenoma Papilliferum that Developed in a Nevus Sebaceus.

Authors:  Mi Sun Kim; June Hyunkyung Lee; Won-Mi Lee; Sook-Ja Son
Journal:  Ann Dermatol       Date:  2010-08-05       Impact factor: 1.444

Review 7.  Mixed tubulopapillary hidradenoma and syringocystadenoma papilliferum occurring as a verrucous tumor.

Authors:  Pai-Jui Hsu; Chao-Hong Liu; Chien-Jen Huang
Journal:  J Cutan Pathol       Date:  2003-03       Impact factor: 1.587

Review 8.  Is tubular apocrine adenoma a distinct clinical entity?

Authors:  A Ishiko; H Shimizu; N Inamoto; K Nakmura
Journal:  Am J Dermatopathol       Date:  1993-10       Impact factor: 1.533

9.  Syringocystadenoma papilliferum with sebaceous differentiation in an intradermal tubular apocrine component. Report of a case.

Authors:  Marina Vazmitel; Michal Michal; Petr Mukensnabl; Dmitry V Kazakov
Journal:  Am J Dermatopathol       Date:  2008-02       Impact factor: 1.533

10.  Syringocystadenoma papilliferum: an unusual cutaneous lesion in a pediatric patient.

Authors:  Tiffany C Townsend; Anneli R Bowen; Kerilyn K Nobuhara
Journal:  J Pediatr       Date:  2004-07       Impact factor: 4.406
View more
  4 in total

1.  Ectopic Tubular Papillary Apocrine Adenoma on the Eyelid: A Case Report of Misleading Clinical Presentation and Location.

Authors:  Laura Abbeel; Rita Van Ginderdeuren
Journal:  Ocul Oncol Pathol       Date:  2018-02-06

2.  Syringocystadenoma papilliferum combined with a tubular apocrine adenoma.

Authors:  Luanna da Silva Brito Léda; Maria do Socorro Ventura Silva Lins; Everson José Dos Santos Leite; Alberto Eduardo Cox Cardoso; Ricardo Luis Simões Houly
Journal:  An Bras Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.896

3.  Combined melanocytic and sweat gland neoplasm: cell subsets harbor an identical HRAS mutation in phacomatosis pigmentokeratotica.

Authors:  Janet Y Li; Michael F Berger; Ashfaq Marghoob; Umesh K Bhanot; Jennifer P Toyohara; Melissa P Pulitzer
Journal:  J Cutan Pathol       Date:  2014-07-09       Impact factor: 1.587

4.  Is Syringocystadenoma Papilliferum Incidental in This Verrucous Carcinoma?

Authors:  Tyler Long; Brian Bonomo; Sydney Shearer; William Welton; Ralph Massullo; George Gibbons
Journal:  Case Rep Pathol       Date:  2019-10-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.